Does Rallies show 13F holders for ACON?

Yes. Rallies tracks hedge fund and 13F ownership data for ACON, including fund names, share counts, latest tracked quarter, and position changes when available.

Is ACON research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ACON. It does not provide personalized investment advice.

ACON (Aclarion, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Aclarion, Inc. Common Stock (ACON) is a publicly traded Healthcare sector company. As of May 21, 2026, ACON trades at $3.14 with a market cap of $7.88M and a P/E ratio of -0.36. ACON moved +2.19% today. Year to date, ACON is -38.42%; over the trailing twelve months it is -54.10%. Its 52-week range spans $2.34 to $3,499.51. Analyst consensus is buy with an average price target of $7.00. Rallies surfaces ACON's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns ACON stock?

Hedge funds tracked by Rallies that own ACON include Citadel Advisors and Two Sigma. The latest tracked quarter is Jun 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Aclarion, Inc. Common Stock.

ACON Key Metrics

Key financial metrics for ACON
Metric	Value
Price	$3.14
Market Cap	$7.88M
P/E Ratio	-0.36
EPS	$-9.03
Dividend Yield	0.00%
52-Week High	$3,499.51
52-Week Low	$2.34
Volume	15
Avg Volume	0
Revenue (TTM)	$77.88K
Net Income	$-8.05M
Gross Margin	19.35%

Top Hedge Funds Holding ACON

Citadel Advisors holds 28.84K shares of ACON, changed +16.06% as of Jun 30, 2024.
Two Sigma holds 16.67K shares of ACON, changed -66.18% as of Dec 31, 2024.

Latest ACON News

Aclarion Logs 196% Scan Volume Surge, CEO Buys Shares and Unveils $2.5M Buyback — May 11, 2026
Aclarion Grants 17,000-Share Option at $3.20 to Commercial Director — May 6, 2026
Aclarion Secures Second Weill Cornell Agreement for Two-Year Nociscan and BMAC Trial — May 5, 2026
Aclarion Q1 Scan Volumes Jump 196% as $2.5M Buyback Boosts Cash Position — Apr 30, 2026
Aclarion Names Daniel Keefe Western U.S. Director After Triple-Digit Nociscan Growth — Apr 28, 2026

Recent ACON Insider Trades

Breidbart Scott bought 5.66K (~$18.01K) on May 12, 2026.
Neal David K bought 2.50K (~$7.75K) on May 11, 2026.
Ness Brent bought 6.29K (~$20.00K) on May 11, 2026.

ACON Analyst Consensus

1 analysts cover ACON: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $7.00.

Common questions about ACON

Who owns ACON stock?: Hedge funds tracked by Rallies that own ACON include Citadel Advisors and Two Sigma. The latest tracked quarter is Jun 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Aclarion, Inc. Common Stock.
Does Rallies show 13F holders for ACON?: Yes. Rallies tracks hedge fund and 13F ownership data for ACON, including fund names, share counts, latest tracked quarter, and position changes when available.
Is ACON research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ACON. It does not provide personalized investment advice.